BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 34103083)

  • 1. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis.
    Oliveira MS; Santo RCE; Silva JMS; Alabarse PVG; Brenol CV; Young SP; Xavier RM
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1657-1669. PubMed ID: 37243418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis.
    Medcalf MR; Bantis LE; Shi P; Bhadbhade P; Gundry RL; Mikuls TR; England BR; O'Dell JR; Funk RS
    Semin Arthritis Rheum; 2022 Oct; 56():152056. PubMed ID: 35785666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels.
    Chen J; Li S; Zhu J; Su W; Jian C; Zhang J; Wu J; Wang T; Zhang W; Zeng F; Chang S; Jia L; Su J; Zhao Y; Wang J; Zeng F
    Arthritis Res Ther; 2023 May; 25(1):74. PubMed ID: 37138305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.
    Cuppen BV; Fu J; van Wietmarschen HA; Harms AC; Koval S; Marijnissen AC; Peeters JJ; Bijlsma JW; Tekstra J; van Laar JM; Hankemeier T; Lafeber FP; van der Greef J;
    PLoS One; 2016; 11(9):e0163087. PubMed ID: 27631111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
    Gonzalez-Ponce F; Gamez-Nava JI; Perez-Guerrero EE; Saldaña-Cruz AM; Vazquez-Villegas ML; Ponce-Guarneros JM; Huerta M; Trujillo X; Contreras-Haro B; Rocha-Muñoz AD; Carrillo-Escalante MO; Sanchez-Rodriguez EN; Gomez-Ramirez EE; Nava-Valdivia CA; Cardona-Muñoz EG; Gonzalez-Lopez L;
    PLoS One; 2021; 16(9):e0255854. PubMed ID: 34506500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the synovial fluid metabolome according to disease activity of rheumatoid arthritis.
    Ahn JK; Kim J; Cheong YE; Kim KH; Cha HS
    Clin Exp Rheumatol; 2020; 38(3):500-507. PubMed ID: 31498072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
    Curtis JR; Brahe CH; Østergaard M; Lund Hetland M; Hambardzumyan K; Saevarsdottir S; Wang X; Flake Ii DD; Sasso EH; Huizinga TW
    Curr Med Res Opin; 2019 Sep; 35(9):1483-1493. PubMed ID: 30777458
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolomic approach to the exploration of biomarkers associated with disease activity in rheumatoid arthritis.
    Sasaki C; Hiraishi T; Oku T; Okuma K; Suzumura K; Hashimoto M; Ito H; Aramori I; Hirayama Y
    PLoS One; 2019; 14(7):e0219400. PubMed ID: 31295280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
    Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
    Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis.
    Yu J; Hu C; Dai Z; Xu J; Zhang L; Deng H; Xu Y; Zhao L; Li M; Liu L; Zhang M; Huang J; Wu L; Chen G
    Int Immunopharmacol; 2023 Jun; 119():110203. PubMed ID: 37094543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
    Yoshii I; Chijiwa T; Sawada N
    Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.